Prevention of cytomegalovirus infection and disease after lung transplantation: Results using a unique regimen employing delayed ganciclovir

Many lung transplant programs employ lengthy regimens of IV ganciclovir therapy to prevent disease due to cytomegalovirus (CMV). In 1994, we introduced a regimen of delayed ganciclovir prophylaxis for CMV infection. This consisted of 2 weeks of IV ganciclovir therapy, initiated 3 to 4 weeks after tr...

Ausführliche Beschreibung